This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loutsch, J. M.
Right arrow Articles by Wechsler, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loutsch, J. M.
Right arrow Articles by Wechsler, S. L.

 Previous Article  |  Next Article 

Journal of Virology, January 1999, p. 767-771, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Identical 371-Base-Pair Deletion Mutations in the LAT Genes of Herpes Simplex Virus Type 1 McKrae and 17syn+ Result in Different In Vivo Reactivation Phenotypes

Jeannette M. Loutsch,1 Guey-Chuen Perng,2 James M. Hill,1 Xiaodong Zheng,1 Mary E. Marquart,1 Timothy M. Block,3 Homayon Ghiasi,2,4 Anthony B. Nesburn,2,4 and Steven L. Wechsler2,4,*

LSU Eye Center, Department of Ophthalmology, Microbiology and Immunology, and Department of Pharmacology, Louisiana State University Medical Center School of Medicine, New Orleans, Louisiana 70112-22341; Ophthalmology Research Laboratories, Cedars-Sinai Medical Center Burns and Allen Research Institute, Los Angeles, California 900482; Jefferson Center for Biomedical Research, Thomas Jefferson College, Doylestown, Pennsylvania 189013; and Department of Ophthalmology, UCLA School of Medicine, Los Angeles, California 900244

Received 25 August 1998/Accepted 13 October 1998

    ABSTRACT
Top
Abstract
Text
References

The herpes simplex virus type 1 (HSV-1) LAT gene is the only viral gene abundantly transcribed during latency. LAT null mutants created with strains McKrae and 17syn+ are impaired for both in vivo spontaneous and in vivo-induced reactivation. Thus, LAT is essential for efficient in vivo-induced and spontaneous reactivation. Different investigators have studied two LAT mutants containing a StyI-StyI region deletion corresponding to LAT nucleotides 76 to 447. One mutant, dLAT371 (parent strain, McKrae), had parental high frequencies of spontaneous reactivation. In vivo-induced reactivation was not examined. The other mutant, 17Delta Sty (parent strain, 17syn+), had parental frequencies of in vitro reactivation following cocultivation of explanted ganglia but reduced frequencies of in vivo-induced reactivation. Spontaneous reactivation frequency was not reported for 17Delta Sty. These combined results suggested the possibility that in vivo spontaneous reactivation and in vivo-induced reactivation may map to different regions within the LAT domain. We now report that dLAT371 has in vivo-induced reactivation frequencies of the parent and that 17Delta Sty has reduced frequencies of in vivo spontaneous reactivation. Thus, dLAT371 demonstrated the parental phenotype for both in vivo spontaneous and -induced reactivation while the apparently identical 17Delta Sty was impaired for both in vivo spontaneous and -induced reactivation. These results suggest that one or more differences between the genetic backgrounds of McKrae and 17syn+ result in different in vivo reactivation phenotypes of otherwise identical deletion mutations and that McKrae may have compensating sequences sufficient to overcome the loss of the StyI-StyI region of the LAT transcript.

    TEXT
Top
Abstract
Text
References

Herpes simplex virus type 1 (HSV-1) can infect the eye, after which it travels by retrograde axonal transport to the trigeminal ganglia and establishes a latent infection that lasts throughout the life of the infected individual. The virus can reactivate sporadically, return to the eye, and cause recurrent disease. This in turn can produce corneal scarring leading to loss of vision. In the industrialized nations, recurrent ocular HSV-1 is the leading cause of infectious corneal blindness (16).

The only viral gene abundantly transcribed during latency is the latency-associated transcript (LAT) (21, 24). LAT is located in the long repeats of the HSV-1 genome and is therefore present in two copies per genome (Fig. 1). LAT is transcribed as an 8.3-kb RNA that gives rise to a family of LAT RNAs, including a very stable 2.0-kb LAT intron (5, 23, 26-28). LAT null mutants incapable of LAT transcription reactivate poorly by explant culture or induced reactivation in the mouse (12, 13, 22), by induced reactivation in the rabbit(2, 10, 25), and by spontaneous reactivation in the rabbit (1, 9, 17, 18).


View larger version (14K):
[in this window]
[in a new window]
 
FIG. 1.   Structures of dLAT371 and 17Delta Sty. The top of the figure shows a schematic representation of the prototypic orientation of HSV-1 (strains McKrae and 17syn+). HSV-1 contains a unique long region and a unique short region, each of which is flanked by inverted repeats. The unique regions are shown as solid lines. The repeats are shown as open rectangles. UL, unique long; US, unique short; TRL, terminal repeat, long; IRL, internal repeat, long; TRS, terminal repeat, short; IRS, internal repeat, short. The long-repeat regions are expanded to show details of the LAT domain and are indicated by the dashed lines. The locations of the genes for ICP0 and ICP34.5 are shown for reference. (A) Detailed enlargement of the internal-repeat region of parental and marker-rescued viruses. This region contains the 8.3-kb primary LAT transcript. The direction of transcription is indicated by the arrowhead. TATA indicates the location (in the genomic DNA) of the LAT promoter TATA box. The start of LAT transcription is indicated as +1, corresponding to nt 118801 of the genome (15, 20). The filled rectangle within the primary 8.3-kb LAT transcript indicates the location of the stable 2-kb LAT intron starting at LAT nt 662. The locations and directions of the ICP34.5 and ICP0 transcripts are shown for reference. In all viruses shown here, the copy of LAT in the terminal long repeat is identical to the internal long repeat (enlargement shown). (B) dLAT371, a McKrae mutant. The 371-nt deletion is indicated by the break in the line and is bounded by the StyI restriction sites at LAT nt 76 and 447. This deletion is present in both copies of LAT (one in each long repeat). (C) 17Delta Sty, a 17syn+ mutant. The StyI-StyI deletion is identical to that shown in panel B. (D) dLAT2903, a McKrae LAT null mutant. The deletion from nt -161 to +1667 encompasses part of the LAT promoter containing the TATA box. The region of LAT downstream of the HpaI site is drawn with a dashed line to indicate that dLAT2903 makes no LAT RNA.

In a previous study, the HSV-1 McKrae-based mutant dLAT371 (Fig. 1B) with a deletion of a 371-nucleotide (nt) StyI-StyI region corresponding to LAT nt 76 to 447 did not affect in vivo spontaneous reactivation in the rabbit ocular model (19). This finding suggests that this region is not essential for efficient spontaneous reactivation. In vivo-induced reactivation was not examined in that study. 17Delta Sty (Fig. 1C), a mutant constructed from HSV-1 17syn+ that had the same StyI-StyI deletion as dLAT371 (14), reactivated poorly in the rabbit ocular model following induced in vivo reactivation by iontophoresis of epinephrine (7). 17Delta Sty-Res (Fig. 1A), the rescued 17Delta Sty mutant, had the high-reactivation phenotype of the parent, 17syn+. Spontaneous reactivation of 17Delta Sty was not reported at that time. Thus, in vivo spontaneous reactivation of dLAT371 is at the parental frequency while in vivo-induced reactivation of 17Delta Sty is reduced.

The present study was directed at determining if dLAT371, like 17Delta Sty, is impaired for in vivo-induced reactivation and if 17Delta Sty, like dLAT371, exhibits the parental phenotype for in vivo spontaneous reactivation. If so, these findings may indicate that in vivo-induced reactivation and in vivo spontaneous reactivation are due to different LAT gene functions. If, however, dLAT371 has the McKrae phenotype for in vivo-induced reactivation and 17Delta Sty is impaired for spontaneous reactivation, there may be a difference between HSV-1 strains McKrae and 17syn+, such that McKrae is able to compensate for a deletion of 371 nt within the LAT gene.

A genetic map of the viruses used in this report is shown schematically in Fig. 1. The top of Fig. 1 illustrates the HSV-1 genome of both McKrae and 17syn+. In each virus, both copies of LAT (one in each long repeat) are identical. For simplicity, in Fig. 1A to D, only an enlargement of the internal long repeat region is shown. Panel A shows the LAT region of both wild-type parental viruses and the marker-rescued viruses, dLAT371R (19), dLAT2903R (17), and 17Delta Sty-Res (14), that have been restored back to the parental phenotype. Panels B and C show the LAT regions of the McKrae-based dLAT371 and the 17syn+-based 17Delta Sty, respectively. Both viruses contain a StyI-StyI deletion in both copies of their LAT genes and are otherwise structurally unaltered from their parents (14, 19). The LAT promoters in dLAT371 and 17Delta Sty are intact, and both mutants appear to have normal LAT expression and RNA processing despite the fact that the primary LAT transcript is 371 nt shorter. Panel D shows dLAT2903, a McKrae-based LAT null mutant that contains a deletion of LAT nt -161 to +1667 relative to the transcription start sites in both copies of the LAT gene. This mutant does not transcribe any detectable LAT RNA and has previously been shown to be impaired for both in vivo spontaneous and -induced reactivation in latently infected rabbits (17).

To ensure that any differences seen between dLAT371 and 17Delta Sty were not due to subtle differences in the rabbit model employed by the two testing laboratories, dLAT371 (constructed and analyzed for spontaneous reactivation by Perng et al. [19]) was sent to the Hill laboratory (the original analysis of 17Delta Sty was by Hill et al. [7]). To examine in vivo spontaneous and -induced reactivation, rabbits were infected with either dLAT371 or 17Delta Sty, their parent viruses McKrae or 17syn+ (positive controls), dLAT2903 (negative control), or the rescuant of 17Delta Sty (17Delta Sty-Res). Inoculations with the McKrae viruses were done in unscarified eyes, since McKrae infects unscarified eyes with very high efficiency. Inoculations with the 17syn+ viruses were done in mildly scarified eyes (2 by 2 crosshatch), to increase the efficiency of the acute infection. Kaufman et al. (11) and Garza and Hill (6) used scarification to infect with McKrae to allow for the synchronization of the initial times the lesions appeared. They did not use scarification when inoculating with 17syn+ and saw similar levels of severity of the lesions with only an alteration in the time interval to the visualization of the lesions. Scarification prior to acute infection does not alter reactivation. The rabbits received 2 × 105 PFU of virus in a 25-µl suspension of tissue culture medium. The acute infection was monitored by slit-lamp microscopy until all eyes demonstrated dendritic lesions (postinoculation [p.i.] days 4 through 7 [7]). Rabbits were considered latently infected when the epithelium recovered from the corneal lesion (p.i. day 21). Latently infected rabbits were allowed to reactivate spontaneously or were induced to reactivation by epinephrine iontophoresis. In either case, a tear film was collected daily from each eye and incubated in tubes containing indicator (primary rabbit kidney) cells for detection of cytopathic effect (7, 8).

To examine in vivo spontaneous reactivation, rabbits were inoculated as described above. Cohorts of latently infected rabbits were established as described above, and spontaneous reactivation was analyzed as previously described (1). The numbers of rabbits, eyes, and swabs tested are shown in Table 1 with respect to the number of positive results over the total number of specimens tested for each parameter. The data shown are totals from two experiments, which produced similar results. Spontaneous reactivation of 17Delta Sty was significantly reduced compared to that of 17syn+ with respect to rabbits (P = 0.03), eyes (P = 0.0005), and swabs (P = 0.0001). The parental phenotype was restored in the marker-rescued strain 17Delta Sty-Res (rabbits and eyes, P = 1.0; swabs, P = 0.53). Thus, the StyI-StyI deletion in 17Delta Sty causes impaired in vivo spontaneous reactivation compared to that of 17syn+.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   In vivo spontaneous reactivationa

The reduced spontaneous reactivation frequencies for 17Delta Sty shown in Table 1 differ from data previously reported for dLAT371, which had the parental phenotype for spontaneous reactivation. For comparison purposes, previous results for McKrae, dLAT371, and dLAT2903 (19) are also reported in Table 1. McKrae and 17syn+ had similar frequencies of spontaneous reactivation (rabbits, P = 0.62; eyes, P = 1.0; swabs, P = 0.42). In contrast, spontaneous reactivation of dLAT371 and 17Delta Sty were significantly different (rabbits, P = 0.04; eyes, P = 0.0008; swabs, P < 0.0001). Furthermore, the reduced spontaneous reactivation of 17Delta Sty appeared similar to the reduced spontaneous reactivation of dLAT2903 (Table 1). These findings confirm that dLAT371 and 17Delta Sty have different spontaneous reactivation phenotypes and indicate that spontaneous reactivation of the 17Delta Sty mutant is similar to that of dLAT2903, a LAT null mutant.

The numbers of rabbits, eyes, and swabs tested for in vivo-induced reactivation are shown in Table 2 with respect to the number of positive results over the total number of specimens tested. Within all three parameters (rabbits, eyes, and swabs), the in vivo-induced reactivation of dLAT371 was not statistically different than that of McKrae but was significantly greater than that of dLAT2903 (Table 2). Thus, in vivo-induced reactivation of dLAT371 did not appear to be reduced. As previously shown by Perng et al. (17), the LAT null mutant dLAT2903 had significantly reduced in vivo-induced reactivation compared to that of the parent McKrae (Table 2) when results for eyes and swabs were compared. The data from rabbits latently infected with dLAT2903 were not significantly different from data for rabbits latently infected with McKrae, and this is probably due to the smaller than usual number of latently infected McKrae rabbits that were induced to reactivate.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   In vivo epinephrine-induced ocular reactivation in latently infected rabbitsa

The results shown in Table 2 indicate that dLAT371 was induced by epinephrine iontophoresis to reactivate. 17Delta Sty had significantly reduced reactivation by epinephrine iontophoresis compared to that of its parent virus, 17syn+ (7). For comparison purposes, the previous 17Delta Sty results are also shown in Table 2. While McKrae and 17syn+ had similar induced reactivation frequencies as evidenced by the swab data (P = 0.2) and rabbit and eye data (P = 1.0), dLAT371 and 17Delta Sty were significantly different with respect to the swab data (P < 0.0001) and rabbit and eye data (P = 0.003). Furthermore, the induced reactivation frequency of 17Delta Sty was similar to that of dLAT2903 (P > 0.7), both of which were reduced. These findings indicate that dLAT371 and 17Delta Sty have different induced reactivation phenotypes and that in vivo-induced reactivation of 17Delta Sty is similar to that of the LAT null mutant dLAT2903.

The McKrae-based mutant dLAT371 and the 17syn+-based mutant 17Delta Sty have identical deletions of the StyI-StyI region within the 5' end of the primary LAT transcript. The structures of both mutants were confirmed by Southern blot analysis (7, 14, 19). Both mutants appear to be unimpaired for LAT transcription, with the exception of a smaller transcript, due to the deletion of LAT nt 76 to 447. The sequences for the first 1.5 kb of the LAT genes in McKrae and 17syn+ are very similar, with approximately 98% identity (4). Their StyI-StyI subregions (LAT nt 76 to 447) have a similar level of homology. Within this region, compared to McKrae, 17syn+ has nine mismatched nucleotides, one inserted nucleotide, and one deleted nucleotide, for an overall nucleotide homology of 97%. Without atypical splicing, there are no well-conserved potential open reading frames in this region of LAT (4). Furthermore, both mutants appear to have their respective parental wild-type phenotypes for in vitro and in vivo replication, acute eye disease, neurovirulence, and rate at which latency is established (7). In addition, the results reported here indicate that the apparent in vivo reactivation differences between results for the dLAT371 and 17Delta Sty mutants from the two laboratories were not due to analysis of in vivo spontaneous reactivation by one laboratory and analysis of in vivo-induced reactivation by the second laboratory. The results were also not due to differences in the techniques or methodologies used by the laboratories analyzing the mutants. It therefore appears that the difference between the in vivo reactivation phenotypes of these otherwise identical mutants was due to genotypic differences in the parental strains.

The finding that the StyI-StyI region of LAT in strain 17syn+ is essential for in vivo-induced reactivation but that this region of LAT in strain McKrae is not essential for this function was unexpected. Since the StyI-StyI region of LAT in 17syn+ plays a role in in vivo reactivation, it is likely that this region is also important in McKrae; however, we found that StyI-StyI is not necessary for induced reactivation in strain dLAT371. This is not the first reported paradox found in HSV reactivation experiments. Bloom et al. (3) reported that a 348-bp deletion in 17syn+ has reduced in vivo-induced reactivation frequencies. In attempting to define the region responsible for the phenotype, three shorter, nonoverlapping deletion mutants were generated (17Delta 110, 17Delta 91, and 17Delta 116) from the 348-bp deletion. These viral constructs had the high in vivo reactivation frequencies of the parent strain, 17syn+ (3). To date, this paradox is not fully understood and new constructs are being generated and additional experiments are being planned. Our findings here suggest that the McKrae background can compensate for the loss of this region in the LAT gene. The compensatory genomic region may lie either within LAT or elsewhere in the genome. However, since LAT has been shown to be essential for parental frequencies of spontaneous reactivation in McKrae, it is likely that the compensatory region lies within LAT. One possibility is that, at least in McKrae, the LAT domain has multiple functional regions. These regions need not all be present to achieve parental in vivo reactivation frequencies. Also, based on the data from 17Delta 348, 17Delta Sty, and dLAT371, it is evident that small manipulations of the HSV-1 genome are enough to disturb the in vivo reactivation phenotypes of these viruses. This hypothesis would help explain why natural selection has resulted in conservation of the entire 8.3-kb primary LAT transcript in all HSV-1 strains examined, despite the finding that just the first 1.5 kb of this transcript is sufficient for high frequencies of spontaneous reactivation in rabbits (18).

    ACKNOWLEDGMENTS

This work was supported by Public Health Service grants EY07566 (S.L.W.), EY10243 (S.L.W.), EY06311 (J.M.H.), and EY02377 (Eye Core Grant); Research to Prevent Blindness; the Discovery Fund for Eye Research; and the Skirball Program in Molecular Ophthalmology.

We thank Maxine Simpson-Evans for expert technical support.

    FOOTNOTES

* Corresponding author. Mailing address: Ophthalmology Research Laboratories, Cedars-Sinai Medical Center Burns and Allen Research Institute, Davis Bldg., Room 5072, 8700 Beverly Blvd., Los Angeles, CA 90048. Phone: (310) 855-6457 or (310) 855-6455. Fax: (310) 652-8411. E-mail: Wechsler{at}CSMC.EDU.

    REFERENCES
Top
Abstract
Text
References

1. Berman, E. J., and J. M. Hill. 1985. Spontaneous ocular shedding of HSV-1 in latently infected rabbits. Investig. Ophthalmol. Vis. Sci. 26:587-590[Abstract/Free Full Text].
2. Bloom, D. C., G. B. Devi-Rao, J. M. Hill, J. G. Stevens, and E. K. Wagner. 1994. Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo. J. Virol. 68:1283-1292[Abstract/Free Full Text].
3. Bloom, D. C., J. M. Hill, G. Devi-Rao, E. K. Wagner, L. T. Feldman, and J. G. Stevens. 1996. A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J. Virol. 70:2449-2459[Abstract].
4. Drolet, B. S., G. C. Perng, J. Cohen, S. M. Slanina, A. Yukht, A. B. Nesburn, and S. L. Wechsler. 1998. The region of the herpes simplex virus type 1 LAT gene involved in spontaneous reactivation does not encode a functional protein. Virology 242:221-232[Medline].
5. Farrell, M. J., A. T. Dobson, and L. T. Feldman. 1991. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. USA 88:790-794[Abstract/Free Full Text].
6. Garza, H. H., Jr., and J. M. Hill. 1997. Effect of a beta-adrenergic antagonist, propranolol, on induced HSV-1 ocular recurrence in latently infected rabbits. Curr. Eye Res. 16:453-458[Medline].
7. Hill, J. M., J. B. Maggioncalda, H. H. Garza, Jr., Y.-H. Su, N. W. Fraser, and T. M. Block. 1996. In vivo epinephrine reactivation of ocular herpes simplex virus type 1 in the rabbit is correlated to a 370-base-pair region located between the promoter and the 5' end of the 2.0-kilobase latency-associated transcript. J. Virol. 70:7270-7274[Abstract/Free Full Text].
8. Hill, J. M., R. J. O'Callaghan, and J. A. Hobden. 1993. Ocular iontophoresis, p. 331-354. In A. K. Mitra (ed.), Ophthalmic drug delivery systems. Marcel Dekker, Inc., New York, N.Y.
9. Hill, J. M., F. Sederati, R. T. Javier, E. K. Wagner, and J. G. Stevens. 1990. Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 174:117-125[Medline].
10. Hill, J. M., R. Wen, and W. P. Halford. 1998. Pathogenesis and molecular biology of HSV latency and ocular reactivation in the rabbit, p. 291-315. In M. S. Brown, and A. R. Maclean (ed.), Herpes simplex virus protocols. Humana Press, Inc., Totowa, N.J.
11. Kaufman, H. E., E. D. Varnell, B. M. Gebhardt, H. W. Thompson, and J. M. Hill. 1996. Propanolol suppression of ocular HSV-1 recurrence and associated corneal lesions following spontaneous reactivation in the rabbit. Curr. Eye Res. 15:680-684[Medline].
12. Leib, D. A., C. L. Bogard, M. Kosz-Vnenchak, K. A. Hicks, D. M. Coen, D. M. Knipe, and P. A. Schaffer. 1989. A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J. Virol. 63:2893-2900[Abstract/Free Full Text].
13. Leib, D. A., K. C. Nadeau, S. A. Rundle, and P. A. Schaffer. 1991. The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency. Proc. Natl. Acad. Sci. USA 88:48-52[Abstract/Free Full Text].
14. Maggioncalda, J., A. Mehta, N. W. Fraser, and T. M. Block. 1994. Analysis of a herpes simplex virus type 1 LAT mutant with a deletion between the putative promoter and the 5' end of the 2.0-kilobase transcript. J. Virol. 68:7816-7824[Abstract/Free Full Text].
15. McGeoch, D. J., M. A. Dalrymple, A. J. Davison, A. Dolan, M. C. Frame, D. McNab, L. J. Perry, J. E. Scott, and P. Taylor. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:1531-1574[Abstract/Free Full Text].
16. Nesburn, A. B. (ed.). 1983. Report of the corneal disease panel: vision research---a national plan, 1983-1987. II, part III. C. V. Mosby, St. Louis, Mo.
17. Perng, G.-C., E. C. Dunkel, P. A. Geary, S. M. Slanina, H. Ghiasl, R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1994. The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J. Virol. 68:8045-8055[Abstract/Free Full Text].
18. Perng, G.-C., H. Ghiasi, S. M. Slanina, A. B. Nesburn, and S. L. Wechsler. 1996. The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J. Virol. 70:976-984[Abstract].
19. Perng, G.-C., S. M. Slanina, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1996. A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1. J. Virol. 70:2014-2018[Abstract].
20. Perry, L. J., and D. J. McGeoch. 1988. The DNA sequences of the long repeat region and adjoining parts of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:2831-2846[Abstract/Free Full Text].
21. Rock, D. L., A. B. Nesburn, H. Ghiasl, J. Ong, T. L. Lewis, J. R. Lokensgard, and S. L. Wechsler. 1987. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61:3820-3826[Abstract/Free Full Text].
22. Sawtell, N. M., and R. L. Thompson. 1992. Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J. Virol. 66:2157-2169[Abstract/Free Full Text].
23. Spivack, J. G., and N. W. Fraser. 1988. Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection. J. Virol. 62:1479-1485[Abstract/Free Full Text].
24. Stevens, J. G., E. K. Wagner, G. B. Devi-Rao, M. L. Cook, and L. T. Feldman. 1987. RNA complementary to a herpesvirus a gene mRNA is prominent in latently infected neurons. Science 235:1056-1059[Abstract/Free Full Text].
25. Trousdale, M. D., I. Steiner, J. G. Spivack, S. L. Deshmane, S. M. Brown, A. R. MacLean, J. H. Subak-Sharpe, and N. W. Fraser. 1991. In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model. J. Virol. 65:6989-6993[Abstract/Free Full Text].
26. Wechsler, S. L., A. B. Nesburn, R. Watson, S. M. Slanina, and H. Ghiasi. 1988. Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J. Virol. 62:4051-4058[Abstract/Free Full Text].
27. Wechsler, S. L., A. B. Nesburn, R. Watson, S. M. Slanina, and H. Ghiasi. 1988. Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J. Gen. Virol. 69:3101-3106[Abstract/Free Full Text].
28. Zwaagstra, J. C., H. Ghiasi, S. M. Slanina, A. B. Nesburn, S. C. Wheatley, K. Lillycrop, J. Wood, D. S. Latchman, K. Patel, and S. L. Wechsler. 1990. Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript. J. Virol. 64:5019-5028[Abstract/Free Full Text].


Journal of Virology, January 1999, p. 767-771, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Miller, C. S., Danaher, R. J., Jacob, R. J. (2006). ICP0 Is Not Required for Efficient Stress-Induced Reactivation of Herpes Simplex Virus Type 1 from Cultured Quiescently Infected Neuronal Cells.. J. Virol. 80: 3360-3368 [Abstract] [Full Text]  
  • Kubat, N. J., Amelio, A. L., Giordani, N. V., Bloom, D. C. (2004). The Herpes Simplex Virus Type 1 Latency-Associated Transcript (LAT) Enhancer/rcr Is Hyperacetylated during Latency Independently of LAT Transcription. J. Virol. 78: 12508-12518 [Abstract] [Full Text]  
  • Perng, G.-C., Esmaili, D., Slanina, S. M., Yukht, A., Ghiasi, H., Osorio, N., Mott, K. R., Maguen, B., Jin, L., Nesburn, A. B., Wechsler, S. L. (2001). Three Herpes Simplex Virus Type 1 Latency-Associated Transcript Mutants with Distinct and Asymmetric Effects on Virulence in Mice Compared with Rabbits. J. Virol. 75: 9018-9028 [Abstract] [Full Text]  
  • Thompson, R. L., Sawtell, N. M. (2001). Herpes Simplex Virus Type 1 Latency-Associated Transcript Gene Promotes Neuronal Survival. J. Virol. 75: 6660-6675 [Abstract] [Full Text]  
  • Perng, G.-C., Slanina, S. M., Yukht, A., Ghiasi, H., Nesburn, A. B., Wechsler, S. L. (2000). The Latency-Associated Transcript Gene Enhances Establishment of Herpes Simplex Virus Type 1 Latency in Rabbits. J. Virol. 74: 1885-1891 [Abstract] [Full Text]  
  • Zheng, X., Marquart, M. E., Loustch, J. M., Shah, P., Sainz, B., Ray, A., O’Callaghan, R. J., Kaufman, H. E., Hill, J. M. (1999). HSV-1 Migration in Latently Infected and Naive Rabbits after Penetrating Keratoplasty. IOVS 40: 2490-2497 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loutsch, J. M.
Right arrow Articles by Wechsler, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loutsch, J. M.
Right arrow Articles by Wechsler, S. L.